KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q3 2025 value amounting to $131.1 million.

  • Vertex Pharmaceuticals' Change in Inventory fell 2816.44% to $131.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $594.3 million, marking a year-over-year increase of 3512.96%. This contributed to the annual value of $517.3 million for FY2024, which is 6020.44% up from last year.
  • Vertex Pharmaceuticals' Change in Inventory amounted to $131.1 million in Q3 2025, which was down 2816.44% from $148.6 million recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Change in Inventory peaked at $182.5 million during Q3 2024, and registered a low of -$2.0 million during Q1 2022.
  • In the last 5 years, Vertex Pharmaceuticals' Change in Inventory had a median value of $78.3 million in 2022 and averaged $79.8 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first crashed by 10877.19% in 2022, then skyrocketed by 423000.0% in 2023.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Change in Inventory stood at $27.0 million in 2021, then soared by 190.0% to $78.3 million in 2022, then dropped by 10.6% to $70.0 million in 2023, then surged by 110.71% to $147.5 million in 2024, then fell by 11.12% to $131.1 million in 2025.
  • Its Change in Inventory was $131.1 million in Q3 2025, compared to $148.6 million in Q2 2025 and $167.1 million in Q1 2025.